Close X

The myESMO community is an international network of over 6'000 oncology professionals, sharing best practices and the latest know-how in cancer treatment and care

Join myESMO
to access our members only benefits

Click to discover ESMO

Already have an
ESMO Account?

 
Username: Password:
Remember me!
Forgot your Password?
Close X

You are trying to access a members only resource.
Please log-in.

 
Username: Password:
Remember me!

Forgot your Password?

join us

Not a Member yet?

Get involved, stay connected:
Join myESMO community today
ESMO FAMILY SITES
ESMO » EDUCATION » ABSTRACTS, VIRTUAL MEETINGS AND MEETING REPORTS

33rd ESMO Congress - Stockholm




AND
OR

To top

  TITLE SESSION AUTHOR
The role of government in cancer prevention 33rd ESMO Congress Adamou Adamos
Parp inhibitors in ovarian cancer 33rd ESMO Congress Calvert Hilary
Global regulatory perspectives on drug safety 33rd ESMO Congress Canetta Renzo
SIGNATURES OF METASTATIC BEHAVIOR IN LUNG ADENOCARCINOMA 33rd ESMO Congress Cappuzzo Federico
Open issues in state-of-the art of adult soft tissue sarcoma (STS) medical therapy 33rd ESMO Congress Casali Paolo G.
Primary prevention in cervical cancer (including a vision from Latin America) 33rd ESMO Congress Cazap Eduardo
High grade lymphoma 33rd ESMO Congress Coiffier Bertrand
Molecular biology of sarcomas 33rd ESMO Congress Coindre Jean-Michel
Met inhibitors: targeting oncogene addiction and expedience 33rd ESMO Congress Comoglio Paolo
Evaluation of predictive markers on circulating tumor cells 33rd ESMO Congress Di Leo Angelo
Chronic myeloid leukemia 33rd ESMO Congress Apperley Jane
Epidemiology and prevention in Arab countries 33rd ESMO Congress El Saghir Nagi S.
Ongoing international clinical trials 33rd ESMO Congress Escudier Bernard
Optimal strategy to increase the resectability of liver/lung metastases 33rd ESMO Congress Falcone Alfredo
Key communication skills 33rd ESMO Congress Fallowfield Lesley
What are the problems to be solved in the future? 33rd ESMO Congress Gore Martin
The impact of imaging and other techniques on choice of treatment 33rd ESMO Congress Groen Harry J.M.
Beyond EGFR targeting-new targets, therapies 33rd ESMO Congress Harrington Kevin
MTOR pathway inhibition in renal cell cancer 33rd ESMO Congress Hudes Gary R.
Conclusion: Will large scale screening lead to the identification of therapeutic targets? 33rd ESMO Congress Klein Christoph
BACK TO TOP BACK TO TOP PRINT THIS PAGE PRINT THIS PAGE